Medication info
Amlojet Tablets 5/5/10 mg (Amlodipine, Rosuvastatin, Ezetimibe)

Amlojet Tablets 5/5/10 mg (Amlodipine, Rosuvastatin, Ezetimibe)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletRosuvastatin Calcium›5.2mg / 1 tabletAmlodipine Besylate›6.944mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
Pink, bi-convex, round, film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle, bottle packaging - 100 tablets/bottle
Approval status
Active

MFDS item code 202402809 · Approved 2024.11.27 · Insurance code 693903940

Summary

Main use
Treatment of hypertension and dyslipidemia, treatment of angina, and reduction of the risk of hospitalization and revascularization
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of amlodipine and the ezetimibe/rosuvastatin combination. ○ Amlodipine <Adults> Administer amlodipine 5mg orally once daily; the dose may be increased up to a maximum of 10 mg daily according to the patient's response. Adjust the dose appropriately according to age and symptoms. ○ Ezetimibe/rosuvastatin The ezetimibe/rosuvastatin combination is administered once daily, with or without food. Primary hypercholesterolemia The dosage range of the ezetimibe/rosuvastatin combination is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting the ezetimibe/rosuvastatin combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 10/20mg once daily.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and dyslipidemia, treatment of angina, and reduction of the risk of hospitalization and revascularization

  • Hypertension
  • fixed coronary occlusion
  • vasospasm
  • vascular constriction
  • myocardial ischemia
  • primary hypercholesterolemia
  • dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL-cholesterol
View approved original text

This medication is used for patients who need to take amlodipine and ezetimibe/rosuvastatin simultaneously. Amlodipine helps treat hypertension and improves myocardial ischemia due to stable angina and variant angina. It also reduces the risk of hospitalization for angina and the risk of coronary vascular procedures in patients with coronary heart disease with normal cardiac output and no heart failure. Ezetimibe/rosuvastatin is used to lower total cholesterol, LDL-cholesterol, Apo B, triglycerides, and non-HDL-cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia, while increasing HDL-cholesterol. This medication improves cardiovascular health by managing both hypertension and dyslipidemia.

How to take

Adult dose

Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of amlodipine and the ezetimibe/rosuvastatin combination. ○ Amlodipine <Adults> Administer amlodipine 5mg orally once daily; the dose may be increased up to a maximum of 10 mg daily according to the patient's response. Adjust the dose appropriately according to age and symptoms. ○ Ezetimibe/rosuvastatin The ezetimibe/rosuvastatin combination is administered once daily, with or without food. Primary hypercholesterolemia The dosage range of the ezetimibe/rosuvastatin combination is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting the ezetimibe/rosuvastatin combination or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased up to a maximum of 10/20mg once daily.

Precautions

This medication has been reported to cause a rare side effect known as rhabdomyolysis, which can lead to severe muscle problems. Therefore, if severe muscle pain or weakness occurs, discontinue use immediately and consult a physician. This medication is contraindicated in certain patients, such as those with allergies to the drug components, pregnant women, and individuals with severe liver or kidney disease. Patients with impaired liver function or specific conditions like hypertension and hypothyroidism should use this medication with caution and have regular liver function tests before and during treatment. This medication may cause side effects such as muscle pain, headache, dyspepsia, and edema, and if any unusual symptoms persist or worsen, notify your doctor. Women who are pregnant or breastfeeding should not use this medication, and women of childbearing age should employ appropriate contraceptive methods while taking it. Elderly patients or those with decreased kidney function are at a higher risk of muscle problems and may require dose adjustments. This medication may interact with other drugs, so inform your doctor or pharmacist about any other medications you are taking. In case of overdose, symptoms such as hypotension and heart problems may occur, so seek appropriate medical treatment immediately. Store this medication out of reach of children and avoid transferring it to another container.

Side effects

Acute renal failure due to myoglobinemia, rhabdomyolysis, increased alanine aminotransferase, increased aspartate aminotransferase, chest pain, edema, generalized edema, headache, upper respiratory tract infection, back pain, dyspnea, acute myocardial infarction, abdominal pain, insomnia, skin nodules, congestion, flushing, fatigue, edema, palpitations, dizziness, drowsiness, nausea, weakness, lethargy, pain, weight gain, weight loss, hypotension, vasculitis, tension, sensory loss, paresthesia, peripheral neuropathy, syncope, dysgeusia, tremor, extrapyramidal disorder, erectile dysfunction, gynecomastia, change in bowel habits, dry mouth, indigestion, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, mood changes, cough, alopecia, hyperhidrosis, purpura, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased frequency of urination, urinary disorders, enuresis, hepatitis, jaundice, increased liver enzyme levels, pruritus, rash, angioedema, polymorphic erythema, myocardial infarction, arrhythmia, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, dermatological rash, maculopapular rash, heaviness, warmth, impaired glucose tolerance, weakness, angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, myasthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenic syndrome, diarrhea, oculobulbar myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms, drug eruptions resembling psoriasis, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal liver failure, non-fatal liver failure, cognitive impairment, decreased memory, forgetfulness, amnesia, memory disorders, confusion, chest pain, chest discomfort, myasthenia, generalized edema, diabetic neuropathy, tremors, epigastric pain, vomiting, gastritis, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum production, runny nose, limb pain, arthralgia, anemia, splenomegaly, conjunctival congestion, renal failure, liver dysfunction, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests, acute renal failure due to myoglobinemia, rhabdomyolysis, acute renal failure, myalgia, myopathy, myositis, myasthenia, oculobulbar myasthenia, muscle cramps, gout, erectile dysfunction, syncope, widespread pain, numbness, paresthesia, chest discomfort, loss of appetite, abdominal bloating, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent exposure to air and moisture, and maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. Proper storage will ensure the safety and efficacy of the medication.

Appearance and packaging

Appearance

Pink, bi-convex, round, film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, bottle packaging - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.